Skip to content

PP&E (Net) at other companies

Medtronic logo
MedtronicMDT
$7.42B+8.5%
LivaNova logo
LivaNovaLIVN
$255.48M+43.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$2.91M+33.5%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$100.69M+30.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$125.33M-4.1%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$2.29M+113%

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s PP&E (net)?
Neuropace, Inc. (NPCE) reported PP&E (net) of $1.28M in Q1 2026.
How has Neuropace, Inc.'s PP&E (net) changed year-over-year?
Neuropace, Inc.'s PP&E (net) increased by 10.6% year-over-year, from $1.16M to $1.28M.
What is the long-term trend for Neuropace, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Neuropace, Inc.'s PP&E (net) has grown at a 16.9% compound annual growth rate (CAGR), from $515K to $1.13M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.